Perceptive Advisors’s Verrica Pharmaceuticals VRCA Stock Holding History

Perceptive Advisors’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-324,967	Closed	-$2.27M	–	109
2024 Q4	$2.27M	Sell	324,967 -384,951	-54%	-$4.23M	0.06%	84
2024 Q3	$10.3M	Hold	709,918	–	–	0.22%	70
2024 Q2	$51.8M	Hold	709,918	–	–	1.25%	22
2024 Q1	$42M	Hold	709,918	–	–	0.74%	46
2023 Q4	$52M	Buy	709,918 +206,020	+41%	+$8.47M	1.16%	26
2023 Q3	$19.6M	Hold	503,898	–	–	0.65%	43
2023 Q2	$29.1M	Hold	503,898	–	–	0.84%	39
2023 Q1	$32.8M	Hold	503,898	–	–	0.97%	33
2022 Q4	$13.9M	Hold	503,898	–	–	0.39%	51
2022 Q3	$14.7M	Hold	503,898	–	–	0.43%	53
2022 Q2	$9.68M	Buy	503,898 +142,857	+40%	+$7.18M	0.3%	61
2022 Q1	$29.3M	Hold	361,041	–	–	0.59%	43
2021 Q4	$33.1M	Hold	361,041	–	–	0.51%	50
2021 Q3	$45.1M	Hold	361,041	–	–	0.66%	38
2021 Q2	$40.8M	Hold	361,041	–	–	0.53%	48
2021 Q1	$54.7M	Buy	361,041 +20,000	+6%	+$2.77M	0.69%	42
2020 Q4	$39.3M	Hold	341,041	–	–	0.42%	54
2020 Q3	$26.4M	Hold	341,041	–	–	0.39%	60
2020 Q2	$37.5M	Hold	341,041	–	–	0.61%	39
2020 Q1	$37.3M	Hold	341,041	–	–	0.97%	24
2019 Q4	$52M	Hold	341,041	–	–	1.03%	21
2019 Q3	$50.3M	Hold	341,041	–	–	1.36%	20
2019 Q2	$39.6M	Hold	341,041	–	–	0.91%	28
2019 Q1	$38.5M	Hold	341,041	–	–	1.09%	26
2018 Q4	$27.8M	Hold	341,041	–	–	1.06%	26
2018 Q3	$55.4M	Hold	341,041	–	–	1.48%	23
2018 Q2	$67.3M	Buy	+341,041	New	+$66.8M	1.76%	13

Other funds holding VRCA

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return

Perceptive Advisors's VRCA Position: Q1 2025 in Review

Perceptive Advisors sold out of Verrica Pharmaceuticals (VRCA) in Q1 2025, closing a stake of 324,967 shares — an estimated $2.27M sold.

Perceptive Advisors first reported a position in VRCA in Q2 2018 and held it in 27 quarters. The position peaked at $67.3M in Q2 2018. 74 funds tracked by Wall St. Rank hold VRCA as of Q1 2025.

Perceptive Advisors reported no remaining Verrica Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Perceptive Advisors sold 324,967 Verrica Pharmaceuticals shares in Q1 2025, an estimated $2.27M.
Perceptive Advisors first reported a position in Verrica Pharmaceuticals in Q2 2018 and held it in 27 quarters.
Perceptive Advisors's Verrica Pharmaceuticals position peaked at $67.3M in Q2 2018.
74 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2025.

Based on Perceptive Advisors's 13F filing for Q1 2025, filed 15 May 2025.